Marathon Group Enters The Rapidly Growing Cannabis And Hemp CBD Wellness Industry With A Newly Formed Wholly Owned Subsidiary
February 13 2019 - 4:27PM
InvestorsHub NewsWire
Marathon Group Enters The Rapidly Growing Cannabis And Hemp CBD
Wellness Industry With A Newly Formed Wholly Owned Subsidiary
MarathonRx, Inc.
WATERBURY, CT -- February 13, 2019 -- InvestorsHub NewsWire
-- Marathon Group Corp. (OTC PDPR) (the “Company” or
“Marathon”) is pleased to announce the formation of their new
subsidiary MarathonRx, Inc.
Marathon has extensive experience in the retail and online
technology markets. As a result, a move to expand their services
into the CBD wellness marketplace will help both small and large
companies deal with the complexities of the unique cannabis
industry.
The CBD market is extensive, ranging from medical uses to
supplements to edibles. In addition to the benefits to humans,
there is a huge market for animal and pet use of CBD products. As a
result of the wide ranging uses of CBD products, the size of the
hemp CBD market alone is projected to reach $22 billion dollars per
year in consumer sales by 2022.
This exponential growth will need to be serviced by specialized
technological solutions. Research reports from various industry
experts, including Deloitte, Brightfield Group and others, indicate
the CBD market could outpace and outgrow the marijuana market in
the next few years. Marathon's expertise in point-of-sale
solutions, e-commerce, advertising, digital marketing and more, is
a perfect fit for providing these solutions.
“We are very excited about the formation of MarathonRx. Our
ability to rapidly scale our technology from small to large
businesses will facilitate strong growth of our subsidiary.
Additionally, we can tailor our technology to meet the specific
needs of the dynamic cannabis industry,” stated MacDonald Tudeme,
President and CEO of Marathon.
MarathonRx’s mission is to deliver the highest quality products
and services to capture a piece of an industry that is projected to
be worth over $100 billion by 2025 in the US and $146 billion
worldwide.
MarathonRx has laid the groundwork for a rapid move into the CBD
field. Discussions are already underway with various labs and
suppliers of top quality CBD products. You can stay up to date with
our progress by visiting our
website: http://www.marathonrx.com and subscribing
to our newsletter for updates.
About MarathonRx, Inc.
MarathonRx is a wholly owned subsidiary of Marathon Group Corp.
(OTC: PDPR), formed to explore the various opportunities that are
available in the booming legal cannabis industry. As the
regulatory landscape continues to evolve for cannabis products and
services, MarathonRx will leverage its parent company’s proven
expertise in point-of-sale solutions, digital marketing,
e-commerce, advertising and lead generation.
About Marathon Group Corp
Marathon Group Corp. (PDPR) is a Connecticut-based software
company engaged in web property development, focused on solving
problems faced by small and medium size businesses.
Safe Harbor Statement
The matters discussed, particularly information regarding future
revenue, earnings, business plans and goals, consist of
forward-looking information within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934 and are subject to the safe harbor created by
these sections and involve risks and uncertainties, which could
cause actual results to differ materially from the forward-looking
information. Such statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that
are difficult to predict. These statements are based on assumptions
and estimates that management believes are reasonable based on
currently available information; however, management’s assumptions
and the Company’s future performance are both subject to a wide
range of business risks and uncertainties, and there is no
assurance that these goals and projections can or will be met. Any
number of factors could cause actual results to differ materially.
The Company undertakes no obligation to publicly update or revise
any forward-looking statements. All forward-looking information
contained herein is subject to the risk factors and uncertainties
described in the Company’s filings with the Securities and Exchange
Commission, which risk factors and uncertainties are incorporated
by reference as though fully set forth herein.
MacDonald Tudeme
jasmactt@gmail.com
Source: Marathon Group Corp.
Marathon (CE) (USOTC:PDPR)
Historical Stock Chart
From Dec 2024 to Jan 2025
Marathon (CE) (USOTC:PDPR)
Historical Stock Chart
From Jan 2024 to Jan 2025